Verve Therapeutics Inc (VERV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -200,068 | -151,716 | -105,958 | -51,975 | -157,387 |
| Depreciation Amortization | -8,927 | -7,106 | -5,087 | -2,728 | 1,777 |
| Accounts payable and accrued liabilities | 3,910 | -589 | 1,471 | 1,485 | -5,216 |
| Other Working Capital | 17,703 | 19,923 | -6,295 | -3,311 | 8,380 |
| Other Operating Activity | 37,833 | 30,619 | 18,811 | 7,433 | 30,114 |
| Operating Cash Flow | $-149,549 | $-108,869 | $-97,058 | $-49,096 | $-122,332 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 36,973 | 43,681 | 54,454 | 18,767 | -142,723 |
| PPE Investments | -9,283 | -7,098 | -6,037 | -3,375 | -13,232 |
| Investing Cash Flow | $27,690 | $36,583 | $48,417 | $15,392 | $-155,955 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 213,035 | 35,194 | 3,271 | 2,103 | 329,739 |
| Other Financing Activity | -458 | 0 | 0 | -65 | -783 |
| Financing Cash Flow | $212,577 | $35,194 | $3,271 | $2,038 | $328,956 |
| Beginning Cash Position | 120,236 | 120,236 | 120,236 | 120,236 | 69,567 |
| End Cash Position | 210,954 | 83,144 | 74,866 | 88,570 | 120,236 |
| Net Cash Flow | $90,718 | $-37,092 | $-45,370 | $-31,666 | $50,669 |
| Free Cash Flow | |||||
| Operating Cash Flow | -149,549 | -108,869 | -97,058 | -49,096 | -122,332 |
| Capital Expenditure | -9,283 | -7,098 | -6,037 | -3,375 | -13,232 |
| Free Cash Flow | -158,832 | -115,967 | -103,095 | -52,471 | -135,564 |